• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

A doctor's bullish case for AI, co-written by AI

cafead

Administrator
Staff member
  • cafead   Apr 12, 2024 at 11:12: AM
via When the former head of Kaiser Permanente's physician group started to write last fall about how the explosion in generative AI would change health care, he worried he might be too optimistic.

Less than a year later, Robert Pearl says he probably wasn't bullish enough, pointing to a rash of health care tools recently announced by AI chipmaker Nvidia.

article source